These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17701437)

  • 1. Adverse reaction to Bacille-Calmette-Guérin vaccine in a HIV positive healthcare worker.
    Garvey JF; Gueret P; McDonnell TJ
    Ir J Med Sci; 2007 Sep; 176(3):237-8. PubMed ID: 17701437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial response: variation in clinical and immune responses to bacille Calmette-Guérin--implications for an improved tuberculosis vaccine.
    Ernst JD
    Clin Infect Dis; 1999 Apr; 28(4):791-3. PubMed ID: 10825040
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacille Calmette-Guerin disease following Bacille Calmette-Guerin vaccination of an HIV-infected health-care worker.
    Vera JH; Hill SC; Rubinstein L
    Int J STD AIDS; 2012 Jul; 23(7):e1-2. PubMed ID: 22844017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical reactogenicity of intradermal bacille Calmette-Guérin vaccination.
    Hoft DF; Leonardi C; Milligan T; Nahass GT; Kemp B; Cook S; Tennant J; Carey M
    Clin Infect Dis; 1999 Apr; 28(4):785-90. PubMed ID: 10825039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us?
    Menzies D
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S71-4. PubMed ID: 11010826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
    Moliva JI; Turner J; Torrelles JB
    Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of Bacillus Calmette-Guerin vaccine in children born to HIV-1 infected women.
    Thaithumyanon P; Thisyakorn U; Punnahitananda S; Praisuwanna P; Ruxrungtham K
    Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):482-6. PubMed ID: 11289006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of bacille Calmette-Guerin vaccination in HIV-positive infants.
    Hussey G; Hawkridge T; Eley B; Nuttall J; Kibel M; Geiter L; Barker L; Behr M; Demers AM
    Clin Infect Dis; 2004 May; 38(9):1333-4; author reply 1334-5. PubMed ID: 15127353
    [No Abstract]   [Full Text] [Related]  

  • 9. Ulcerated lupus vulgaris at the site of Bacille Calmette-Guérin vaccination.
    Singal A; Sonthalia S; Pandhi D
    Pediatr Dermatol; 2013; 30(1):147-8. PubMed ID: 22084942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late bacille Calmette-Guérin infection with a large focal urinary bladder ulceration as a complication of bladder cancer treatment.
    Ströck V; Dotevall L; Sandberg T; Gustafsson CK; Holmäng S
    BJU Int; 2011 May; 107(10):1592-7. PubMed ID: 21166754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected children.
    Hesseling AC; Schaaf HS; Hanekom WA; Beyers N; Cotton MF; Gie RP; Marais BJ; van Helden P; Warren RM
    Clin Infect Dis; 2003 Nov; 37(9):1226-33. PubMed ID: 14557968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacille Calmette-Guérin immunization in normal healthy adults.
    Brewer MA; Edwards KM; Palmer PS; Hinson HP
    J Infect Dis; 1994 Aug; 170(2):476-9. PubMed ID: 8035041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated Bacille Calmette-Guerin (BCG) disease in an infant with severe combined immunodeficiency.
    Sohail S; Afzal M; Anwar V; Shama Q
    J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S259-61. PubMed ID: 25518795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV-infection, AIDS and BCG vaccination].
    Toida I
    Kekkaku; 1993 Jun; 68(6):435-44. PubMed ID: 8341039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG lymphadenitis in an HIV-infected child 9.5 years after vaccination.
    Hofstadler G; Schmitt K; Tulzer G; Binder L; Brandstetter B
    AIDS Patient Care STDS; 1998 Sep; 12(9):677-80. PubMed ID: 15468440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular microbiological investigation of post-vaccination bacille Calmette-Guérin infection in Iranian patients.
    Shojaei H; Rahimi-Hajiabadi H; Heidarieh P; Hashemi-Shahraki A; Emadoleslami M; Ataei B; Naser AD
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1497-503, i. PubMed ID: 22008763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
    MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated bacille Calmette-Guérin infection in an AIDS patient 30 years after BCG vaccination.
    Armbruster C; Junker W; Vetter N; Jaksch G
    J Infect Dis; 1990 Nov; 162(5):1216. PubMed ID: 2230251
    [No Abstract]   [Full Text] [Related]  

  • 19. Surgical complications of bacille Calmette-Guérin (BCG) infection in HIV-infected children: time for a change in policy.
    Karpelowsky JS; Alexander AG; Peek SD; Millar AJ; Rode H
    S Afr Med J; 2008 Oct; 98(10):801-4. PubMed ID: 19115758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
    Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.